After implementing a restructuring plan, Urologix Inc. has recorded a decrease in revenue.

The Minneapolis-based company develops, manufactures and markets minimally invasive medical products used to treat benign prostatic hyperplasia, or enlarged prostate disease.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.